Revvity supports Cell & Gene Therapy developers in their discovery and pre-clinical stage with designing and optimizing the manufacturing of viral vectors (AAV, LV, AV), developing technologies that can boost therapy efficiencies like proprietary AAV capsids via evolution and rational design, or even LentiBOOST that can boost LV transduction.

With 2023 revenue of more than $2.7 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.

LentiBOOST™ Pharma-Grade: For research use only. Not for use in diagnostic procedures.

Octapharma are the world’s largest privately owned plasma fractionator, with over 40 years of experience in the industry. Octapharma produce a range of GMP grade plasma derived proteins and serum media additives for the Life Sciences sector. Suitable for Cell & Gene Therapy, Vaccine Development, RNA/DNA Therapeutics, In Vitro Diagnostics, Immunoassays, and wider CDMO/CRO/CMO usage. All proteins are GMP grade, produced to a medicinal standard, and double-pathogen reduced. Bespoke and tailored regulatory documents can also be supplied to support approval body submission where material is listed as an excipient. With several concentrations available for each product, we can confidently support small-scale laboratory use, right through to end product manufacture, supporting all paces of company scale-up.

SAMUEL WALSH | LinkedIn

Part of the PHC Group, a global healthcare company, PHC Europe B.V. are specialists in the sales and support of biomedical products for sample preservation and storage, medical and pharmaceutical storage, incubation and cell culture. Our products are designed to provide precision, high performance, energy efficiency and sample security. **NEW** we are pleased to launch Licellmo, continuous measurement of glucose and lactate in culture medium to visualize real-time changes in cell metabolism**. We also supply a range of ultra-low attachment (ULA) culture dishes and plates for 3D cell culture applications and packaging systems for transporting cells. Our in-house service team can support customers with installation & IOQ validation services and ongoing service and maintenance packages.

PHC Europe B.V.   9 The Office Village, North Road. Loughborough. LE11 1QJ.

The European Society of Gene and Cell Therapy has as its objective the promotion of science and research. We achieve this in part via scientific and educational activities, in particular through measures aimed at the promotion and exchange of information and ideas in gene therapy, cell therapy and genetic vaccination, and the encouragement of research fields and clinical applications.​ We support the activities of national gene and cell therapy societies that share this goal, and we are pleased to endorse the BSGCT in this regard.

https://www.esgct.eu/

Since 1998, Aldevron has been providing clients with specialized manufacturing solutions to advance cell and gene therapy development. Aldevron accelerates the path from pre-clinical research through to clinical trials and commercial supply with phase-appropriate quality and scale, along with experienced support with process development, assay development, analytics, and regulatory support

https://www.aldevron.com/

Bio-Techne is a global developer, manufacturer and supplier of high-quality reagents, analytical instruments, and precision diagnostics. Whether you’re at the cutting edge of academic research, translating basic discoveries to therapeutic leads, or at a facility that requires the highest level of diagnostic testing, our award-winning tools and solutions empower scientists and clinicians to achieve reproducible and consistent results. Trusting Bio-Techne means choosing confidence that every solution you use will help move you toward better answers.

https://www.bio-techne.com/

As a company of Scientists Helping Scientists, STEMCELL Technologies is committed to enabling cell and gene therapy research around the world with high-quality services and solutions. Whether you’re editing CD34+ cells, differentiating PSCs, or expanding immune cells, we have the specialized cell isolation products, cell culture media, and reagents you need. Through our Services for Cell Therapy Program, we can help you qualify our products for use as ancillary materials. Learn more at www.STEMCELL.com.

Thermo Fisher Scientific is a global leader in serving science, providing innovative products and services across various industries.

For cell and gene therapy customers, Thermo Fisher offers: High-quality media and supplements, Tools for gene editing (e.g., CRISPR and Viral vectors production systems) and delivery systems, Instruments and assays for cell process and analysis. Additionally, Thermo Fisher’s CTS™ (Cell Therapy Systems) trademark denotes products designed for clinical research and commercial manufacturing, ensuring high quality and regulatory compliance to accelerate the development of cell and gene therapies.

https://www.thermofisher.com/uk/en/home.html

PackGene Biotech is a world-leading CRO and CDMO, excelling in AAV vectors, mRNA, plasmid DNA, and lentiviral vector solutions. Our comprehensive offerings span from vector design and construction to AAV, lentivirus, and mRNA services. With a sharp focus on early-stage drug discovery, preclinical development, and cell and gene therapy trials, we deliver cost-effective, dependable, and scalable production solutions. Leveraging our groundbreaking π-alpha 293 AAV high-yield platform, we amplify AAV production by up to 10-fold, yielding up to 1e+17vg per batch to meet diverse commercial and clinical project needs. Moreover, our tailored mRNA and LNP products and services cater to every stage of drug and vaccine development, from research to GMP production, providing a seamless, end-to-end solution.

https://www.packgene.com/

GENEWIZ, from Azenta Life Sciences, empowers research by providing high-quality, reliable, precision-based solutions from research use only to pre-clinical/ clinical, enabling scientists to make breakthroughs faster and more efficiently. Key services include Sanger sequencing, next-generation sequencing (NGS), gene synthesis, Gene-to-Discovery solutions including antibody production, viral packaging, and mRNA synthesis. For more information visit https://www.genewiz.com/

Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information visit www.azenta.com

For over 45 years we have been helping scientists find the answers. Going beyond a focus on products, we recognize your challenges and collaborate to develop next-generation solutions and bring a network of diverse ideas to drive better results.

To find out more visit our website Promega Corporation

The British Society for Genetic Medicine  provides a forum for professionals involved in genetics and genomics as a clinical service and research.

The BSGM is an independent professional body. We bring together people working in genetics and genomics disciplines, undertake educational activities, provide information, offer informed opinion and issue statements on important aspects of human genetics.

The British Society for Genetic Medicine, founded in 1996 as the British Society for Human Genetics, provides a forum for professionals involved in genetics and genomics as a clinical service and research.

As an umbrella organisation, our membership includes a wide spectrum of clinical, laboratory and research disciplines.  Originally our members were mainly drawn from those working in specialist NHS regional genetic services and research departments, but now they include health professionals from a wide range of clinical disciplines, who use genetics and genomics as part of their clinical care.  We are pleased to welcome increasing numbers of genomic scientists and bio-informaticians who use genomic technologies to generate and interpret large bodies of data, to find genetic susceptibilities to disease and responses to treatment, both for populations and individuals.

About – The British Society for Genetic Medicine

Ascend Advanced Therapies and ABL Inc. form a premier CDMO alliance with 50+ years of viral manufacturing expertise. We deliver high-quality, cost-effective development and commercial-scale manufacturing of AAV gene therapies, viral oncolytics, and vaccines—accelerating time-to-market for biotech innovators across multiple advanced therapy modalities.

www.ascend-adv.com